title: [Atrial fibrillation: the most common arrhythmia].
abstract: The incidence of atrial fibrillation increases rapidly with population age. Atrial fibrillation essentially presents a problem of long-term management. Strategies of rhythm or rate control should be considered on a case-by-case basis for each individual. Anticoagulation treatment is indicated in most cases. Radiofrequency ablation by pulmonary vein isolation is an unquestionably innovative treatment but is reserved for selected patients.
authors.affiliation: Service de cardiologie A, Hôpital européen Georges Pompidou, F-75015 Paris, France. jean-yves.le-heuzey@egp.aphp.fr
authors.forename: Jean-Yves
authors.initials: JY
authors.lastname: Le Heuzey
authors.forename: Akli
authors.initials: A
authors.lastname: Otmani
authors.forename: Eloi
authors.initials: E
authors.lastname: Marijon
authors.forename: Xavier
authors.initials: X
authors.lastname: Waintraub
authors.forename: Antoine
authors.initials: A
authors.lastname: Lepillier
authors.forename: Karim
authors.initials: K
authors.lastname: Chachoua
authors.forename: Thomas
authors.initials: T
authors.lastname: Lavergne
authors.forename: Maurice
authors.initials: M
authors.lastname: Pornin
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D017115:Catheter Ablation; D003952:Diagnostic Imaging; D004554:Electric Countershock; D004562:Electrocardiography; D006801:Humans; D011379:Prognosis; D013923:Thromboembolism / Q000517:prevention & control
chemical_list: D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants